Parameter | P-Value | Odds Ratio | 95% Confidence Interval | |
---|---|---|---|---|
Age (Years) | <0.001 | 1.051 | 1.043 | 1.059 |
Gender (men / Women) | <0.001 | 0.602 | 0.524 | 0.692 |
Rural / Urban Region of Habitation | <0.001 | 1.185 | 1.142 | 1.231 |
Body Mass Index (kg/m2) | <0.001 | 0.954 | 0.937 | 0.972 |
Level of Education (1–5) | <0.001 | 1.139 | 1.063 | 1.220 |
Self-Reported Income | <0.001 | 1.119 | 1.084 | 1.156 |
Cognitive Score | 0.186 | 0.987 | 0.967 | 1.007 |
Alcohol Consumption Frequency | 0.765 | 0.994 | 0.955 | 1.034 |
Smoking Never / Ever | 0.549 | 1.048 | 0.899 | 1.222 |
Smoking Package Years | 0.941 | 1.001 | 0.964 | 1.040 |
Hours Spent With Vigorously Intensive Physical Activities Per Week | 0.824 | 0.991 | 0.913 | 1.075 |
Hours Spent With Moderate Physical Activities Per week | <0.001 | 0.915 | 0.890 | 0.941 |
Number of Hours Spent With Walking Per Week | 0.109 | 1.026 | 0.994 | 1.058 |
Number of Hours Spent With Sitting Per Week | 0.202 | 1.018 | 0.990 | 1.047 |
Hypertension history | 0.436 | 1.060 | 0.916 | 1.225 |
Cardiovascular disease history | 0.009 | 1.281 | 1.063 | 1.542 |
Diabetes history | 0.705 | 0.959 | 0.770 | 1.194 |
Systolic Blood Pressure (mmHg) | 0.798 | 1.000 | 0.996 | 1.003 |
Diastolic Blood Pressure (mmHg) | <0.001 | 0.988 | 0.983 | 0.994 |
Mean Blood Pressure (mmHg) | 0.180 | 0.987 | 0.967 | 1.006 |
Glucose (mmol/L) | 0.020 | 0.932 | 0.878 | 0.989 |
Cholesterol (mmol/L) | 0.080 | 0.926 | 0.849 | 1.009 |
Creatinine | <0.001 | 1.011 | 1.005 | 1.017 |
High-Density Lipoproteins (mmol/L) | 0.219 | 1.142 | 0.924 | 1.411 |
Low-Density Lipoproteins (mmol/L) | 0.022 | 0.894 | 0.812 | 0.984 |
Triglycerides (mmol/L) | 0.044 | 0.926 | 0.859 | 0.998 |
Use of Aspirin Yes / No | 0.255 | 1.093 | 0.938 | 1.275 |
Depression Score | 0.674 | 0.998 | 0.987 | 1.009 |
Ophthalmological Parameters | ||||
Visual Acuity | <0.001 | 0.341 | 0.273 | 0.427 |
BCVA(LogMAR) | <0.001 | 2.291 | 1.543 | 3.400 |
Axial Length (mm) | <0.001 | 1.650 | 1.532 | 1.778 |
refractive errors | <0.001 | 0.825 | 0.793 | 0.858 |
Anterior Corneal Curvature Radius (mm) | <0.001 | 2.387 | 1.792 | 3.180 |
Central Corneal Thickness (μm) | 0.007 | 1.003 | 1.001 | 1.005 |
Anterior Chamber Depth (mm) | <0.001 | 1.466 | 1.265 | 1.698 |
Lens Thickness (mm) | <0.001 | 1.579 | 1.264 | 1.973 |
Intraocular Pressure mmHg) | 0.908 | 0.998 | 0.973 | 1.024 |
Retinal Nerve Fiber Layer Thickness (μm) | <0.001 | 0.964 | 0.958 | 0.970 |
Subfoveal Choroidal Thickness (μm) | <0.001 | 0.993 | 0.992 | 0.993 |
Fundus Tessellation | 0.666 | 1.151 | 0.608 | 2.182 |
Macular Retinal Thickness (μm) | 0.277 | 0.998 | 0.996 | 1.001 |
Optic Disc Size (mm2) | <0.001 | 1.756 | 1.491 | 2.068 |
Nuclear Cataract | <0.001 | 1.201 | 1.121 | 1.288 |
Cortical Cataract | 0.240 | 1.369 | 0.811 | 2.310 |
Subcapsular Posterior Cataract | 0.104 | 0.113 | 0.008 | 1.563 |
Glaucoma history | 0.012 | 1.727 | 1.126 | 2.648 |
Glaucoma prevalence | <0.001 | 2.538 | 1.882 | 3.424 |
Age-Related Macular Degeneration, Prevalence, Total | 0.006 | 0.819 | 0.710 | 0.944 |
Age-Related Macular Degeneration, Early Stage | 0.428 | 0.902 | 0.699 | 1.164 |
Age-Related Macular Degeneration, Intermediate Stage | 0.010 | 0.783 | 0.650 | 0.943 |
Age-Related Macular Degeneration, Late Stage | 0.145 | 1.740 | 0.825 | 3.669 |
Diabetic Retinopathy, Prevalence | 0.787 | 1.093 | 0.572 | 2.091 |
Retinal Vein Occlusion, Total | 0.052 | 1.500 | 0.997 | 2.256 |
Polypoidal Choroidal Vasculopathy | 0.120 | 2.158 | 0.819 | 5.683 |